Case Report: Response to crizotinib treatment in a patient with advanced non-small cell lung cancer with LDLR-ROS1 fusion

C-ros oncogene 1 (ROS1) fusion is a pathogenic driver gene in non-small cell lung cancer (NSCLC). Currently, clinical guidelines from the National Comprehensive Cancer Network (NCCN) have recommended molecular pathologic tests for patients with NSCLC, including the detection of the ROS1 gene. Crizot...

Descripción completa

Detalles Bibliográficos
Autores principales: Shu, Yun, Wang, Zhouyu, Shang, Hongjuan, Le, Wei, Lei, Yan, Huang, Longzhang, Tao, Liming, Chen, Jun, Li, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157030/
https://www.ncbi.nlm.nih.gov/pubmed/37152007
http://dx.doi.org/10.3389/fonc.2023.1169876

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157030/
https://www.ncbi.nlm.nih.gov/pubmed/37152007
http://dx.doi.org/10.3389/fonc.2023.1169876

Ejemplares similares